WO2012152796A1
2012-05-08
Assembly for the sealing of bottles containing injectable sterile medicines or similar substances, suitable for use in high-speed lines of production of the bottles, respective sealing cap and corresponding sealed bottle
WO2008068276A1
2007-12-05
Soft gelatin capsules comprising acetylsalicylic acid
CA2510985A1
2005-06-28
Pharmaceutical formulations for the safe administration of drugs used in the treatment of drug addiction and processes for obtaining the same
JP2006008684A
2005-06-15
Injectable pharmaceutical composition having dichlofenac sodium and beta-cyclodextrin
EP1593688A1
2005-05-02
Method for partition and inactivation of viral and prion contaminants
EP1561698A1
2004-02-05
Dropper bottle
EP1352648A1
2003-04-07
Pharmaceutical compositions of acetylsalicylic acid and omega-3 oils
CA2408681A1
2002-10-17
Process for the preparation of chondroitin sulfates from k4 polysaccharide and obtained products
EP1243260A1
2002-03-21
Cicatrizant hydrocolloidal patch containing hyaluronic acid and chondroitin sulphate
EP1197217A1
2001-09-27
Use of sodium nitroprussiate in obstetrics and gynaecology
JP2001323000A
2000-05-17
Separation and purification of fhs(follicule stimulating hormone) and lh (interstitial cell-stimulating hormone)
US6162905A
1998-07-06
FSH and LH separation and purification process
EP0882064A1
1997-11-03
Fsh and lh separation and purification process
EP0704216A1
1995-07-28
Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration
ITMI940068D0
1994-01-19
Process for the preparation of chondroitin sulphate
US5388690A
1993-11-15
Proportioning device for extemporaneous multidose syrups
EP0340662A1
1989-04-28
Solid, water-soluble, pharmaceutical composition containing acetylcysteine
NL8002480A
1980-04-28
Conversion of penicillin or cephalosporin cpds. - using immobilised enzymes to give highly pure prods. free from side effects
